Overview
The overall focus of this laboratory has been the study of the genetic regulation of normal and leukemic hematopoietic cells. Hematopoietic stem cells are produced during embryonic and fetal development and migrate to fetal liver, spleen, thymus, and bone marrow to populate those organs for the "definitive" stages of hematopoiesis.
We initially cloned the genes that compose the beta globin gene locus and also characterized other genomic elements that reside in and help control the expression of the locus, including the discovery of L1 repeats. We later identified specific regulatory elements that when mutated change the expression of the locus, resulting in persistent expression of fetal globins into adulthood. Our description of mutations in globin genes also explained an unusual form of thalassemia.
Our focus shifted to the identification and characterization of genes that control hematopoiesis, especially the human c-kit gene, normally expressed on erythroid progenitors. We identified important regulatory elements in the gene and how it interacted with other hematopoietic transcription factors. Later we identified the ets transcription factors as mediators of its signaling pathway and isolated a novel ets transcription factor, designated PE-2/ERF. Finally, we characterized the human GATA-1 and GATA-2 gene regulatory elements and demonstrated that signaling through the Kit signal transduction pathway has direct effects on these genes, showing that Kit signal transduction in setting up the erythroid developmental program.
This laboratory also has isolated the gene encoding the T cell specific gene CD7, expressed in T cell progenitors. During the characterization of the regulation of this gene, we identified a novel gene, SECTM1, that is closely linked physically and is the ligand for CD7. SECTM1 plays a role in regulating the immune response as well as other biological functions, and this is our current focus.
Key Words: Hematopoiesis, c-kit, ets, erythropoiesis, leukemia, gene regulation
for more information, see http:marini.biochem.duke.edu/Faculty/Kaufman.html
We initially cloned the genes that compose the beta globin gene locus and also characterized other genomic elements that reside in and help control the expression of the locus, including the discovery of L1 repeats. We later identified specific regulatory elements that when mutated change the expression of the locus, resulting in persistent expression of fetal globins into adulthood. Our description of mutations in globin genes also explained an unusual form of thalassemia.
Our focus shifted to the identification and characterization of genes that control hematopoiesis, especially the human c-kit gene, normally expressed on erythroid progenitors. We identified important regulatory elements in the gene and how it interacted with other hematopoietic transcription factors. Later we identified the ets transcription factors as mediators of its signaling pathway and isolated a novel ets transcription factor, designated PE-2/ERF. Finally, we characterized the human GATA-1 and GATA-2 gene regulatory elements and demonstrated that signaling through the Kit signal transduction pathway has direct effects on these genes, showing that Kit signal transduction in setting up the erythroid developmental program.
This laboratory also has isolated the gene encoding the T cell specific gene CD7, expressed in T cell progenitors. During the characterization of the regulation of this gene, we identified a novel gene, SECTM1, that is closely linked physically and is the ligand for CD7. SECTM1 plays a role in regulating the immune response as well as other biological functions, and this is our current focus.
Key Words: Hematopoiesis, c-kit, ets, erythropoiesis, leukemia, gene regulation
for more information, see http:marini.biochem.duke.edu/Faculty/Kaufman.html
Current Appointments & Affiliations
Professor Emeritus of Medicine
·
2002 - Present
Medicine, Medical Oncology,
Medicine
Recent Publications
In Vitro Differentiation of Tumor-Associated Macrophages from Monocyte Precursors with Modified Melanoma-Conditioned Medium.
Chapter · 2021 Tumor-associated macrophages (TAMs) are one of most important components of the tumor microenvironment. Although many assays have been developed to differentiate monocytes into macrophages (Mϕ) for studying the biology of TAMs in vitro, little is known whe ... Full text Open Access Link to item CiteGenetic Testing Gone Wild.
Journal Article Managed Care (Langhorne, Pa.) · 2019 CiteThe macrophage: Switches from a passenger to a driver during anticancer therapy.
Journal Article Oncoimmunology · December 2015 We have recently discovered that BRAF inhibitors induce potent macrophage responses that confer melanoma resistance to therapy. Our studies lay a foundation for the hypothesis that macrophages switch their role from a passenger to a driver for tumor surviv ... Full text Open Access Link to item CiteRecent Grants
Yr5 Role Of Platelet-Derived Growth Factor In The Pathogen
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 1993 - 2003Duke/Unc Comprehensive Sickle Cell Center
ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 1977 - 2000Comprehensive Cancer Center Core Support Grant
ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 1976 - 1998View All Grants
Education, Training & Certifications
Ohio State University ·
1973
M.D.